Cognitive Screening within Advanced Pharmaceutical Care in Elderly Patients with Suspected Metabolic Syndrome
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00159816%3A_____%2F22%3A00077731" target="_blank" >RIV/00159816:_____/22:00077731 - isvavai.cz</a>
Alternative codes found
RIV/00064203:_____/22:10451361 RIV/00216208:11130/22:10451361
Result on the web
<a href="https://www.airitilibrary.com/Publication/alDetailedMesh?DocID=P20190312001-202210-202210140002-202210140002-355-360" target="_blank" >https://www.airitilibrary.com/Publication/alDetailedMesh?DocID=P20190312001-202210-202210140002-202210140002-355-360</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.6890/IJGE.202210_16(4).0008" target="_blank" >10.6890/IJGE.202210_16(4).0008</a>
Alternative languages
Result language
angličtina
Original language name
Cognitive Screening within Advanced Pharmaceutical Care in Elderly Patients with Suspected Metabolic Syndrome
Original language description
Background: Cognitive screening by pharmacists may help to identify seniors with metabolic syndrome (MetS)-related cognitive impairment. We aimed to evaluate the implementation of an easy-to-use cognitive screening into the pharmaceutical care of seniors and to test whether cognitive decline is associated with suspected MetS (sMetS).Methods: Questionnaires were completed by 323 randomly selected elderly patients receiving pharmaceutical care in community pharmacies or in senior care centres in Slovakia. The presence of sMetS was estimated according to criteria of the International Diabetes Federation. Cognitive performance was evaluated by the Montreal Cognitive Assessment (MoCA) test and its short form (s-MoCA). In these tests, the cut-offs for impaired cognitive status were <= 24, and <= 12, respectively.Results: 56% of participants scored below the screening cut-off MoCA threshold. Cognitive impairment was significantly more frequent in sMetS+ subjects (71%) vs. sMetS- (52%; p < 0.05). MoCA scores were significantly lower in sMetS+ (mean +/- SD = 20.0 +/- 5.9 points) vs. sMetS- (22.2 +/- 5.4 points; p < 0.05). sMetS components type 2 diabetes mellitus, hypertension and obesity, but not dyslipidaemia, had an influence on lower cognitive performance.Conclusions: We unveiled a significant relationship of cognitive dysfunction to sMetS in elderly patients. A quick and simple cognitive assessment could be a helpful extension of pharmaceutical care.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30227 - Geriatrics and gerontology
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2022
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
International Journal of Gerontology
ISSN
1873-9598
e-ISSN
1873-958X
Volume of the periodical
16
Issue of the periodical within the volume
4
Country of publishing house
TW - TAIWAN (PROVINCE OF CHINA)
Number of pages
6
Pages from-to
355-360
UT code for WoS article
000888027600009
EID of the result in the Scopus database
—